Thomas Klingebiel

10PUBLICATIONS
105CO-AUTHORS
HaematologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapySolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 06, 2026
First-in-Human Study of IL15-Activated Cytokine-Induced Killer Cells After Allogeneic HCT Shows Durable Remission and Serotherapy-Associated Immune Reconstitution in Leukemia.

Eva Rettinger, Dirk Heckl, Martin Hutter

|Jul 08, 2025
Fcγ Receptor Polymorphism in Patients with Relapsed/Refractory High-Risk Neuroblastoma Correlates with Outcomes in the SIOPEN Dinutuximab Beta Long-Term Infusion Trial.

Holger N Lode, Nikolai Siebert, Dominique Valteau-Couanet

|Jan 11, 2025
Long-Term Outcomes and Quality of Life of High-Risk Neuroblastoma Patients Treated with a Multimodal Treatment Including Anti-GD2 Immunotherapy: A Retrospective Cohort Study.

Tim Flaadt, Jonas Rehm, Thorsten Simon

|Sep 19, 2023
Which Patients With Rhabdomyosarcoma Need Radiotherapy? Analysis of the Radiotherapy Strategies of the CWS-96 and CWS-2002P Studies and SoTiSaR Registry.

Ewa Koscielniak, Beate Timmermann, Marc Münter

|Apr 13, 2023
Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials.

Lars Tramsen, Konrad Bochennek, Monika Sparber-Sauer

|Dec 09, 2022
Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL.

Franco Locatelli, Gerhard Zugmaier, Carmelo Rizzari

Pageof 2

Frequent Collaborators

4 joint publications

Uta Dirksen

3 joint publications

Bernd Gruhn

3 joint publications

Monika Sparber-Sauer

2 joint publications

U Thiel